Parents' experiences of expanded newborn screening evaluations
- PMID: 21708804
- DOI: 10.1542/peds.2010-3413
Parents' experiences of expanded newborn screening evaluations
Abstract
Objective: Abnormal results of newborn screening for common metabolic diseases are known to create substantial distress for parents. We explored parents' perceptions during diagnostic evaluations for newer disorders that are less well understood.
Methods: Thirty families completed 48 open-ended interviews before and/or after parents received confirmatory test results for their infants. Qualitative content analysis was used to analyze the data.
Results: Parents were shocked by the notification of the abnormal test result. Their urgent and often frustrating searches for information dominated the early phase of the screening process. Treatment center personnel were mainly informative and reassuring, but waiting for results exacerbated parents' distress. Equivocal results from diagnostic testing created uncertainties for parents regarding their infants' long-term health. After counseling, some parents reported inaccurate ideas about the disorders despite exposure to large amounts of information. Regardless of the challenges and anxieties of the evaluation, nearly every parent thought newborn screening was an important program for infant health.
Conclusions: The evaluation of a newborn for an abnormal screening result was highly stressful for parents. To help reduce parents' distress, improvements in communications and clinical services are needed. Recommendations of useful Internet sites and discussions of this information may benefit parents. Tailoring counseling to meet the needs of culturally and educationally diverse families is needed. Families and infants with equivocal results are a new group of patients who merit comprehensive clinical follow-up.
Copyright © 2011 by the American Academy of Pediatrics.
Similar articles
-
Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.Pediatrics. 2005 Jun;115(6):1692-703. doi: 10.1542/peds.2004-0275. Pediatrics. 2005. PMID: 15930234
-
Inconclusive cystic fibrosis neonatal screening results: long-term psychosocial effects on parents.Acta Paediatr. 2009 Dec;98(12):1927-34. doi: 10.1111/j.1651-2227.2009.01485.x. Epub 2009 Aug 18. Acta Paediatr. 2009. PMID: 19689478
-
Parents' decision-making in newborn screening: opinions, choices, and information needs.Pediatrics. 2010 Oct;126(4):696-704. doi: 10.1542/peds.2010-0217. Epub 2010 Sep 13. Pediatrics. 2010. PMID: 20837593
-
Expanded newborn screening: information and resources for the family physician.Am Fam Physician. 2008 Apr 1;77(7):987-94. Am Fam Physician. 2008. PMID: 18441864 Review.
-
Inborn errors of metabolism: new challenges with expanded newborn screening programs.Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):61-3. doi: 10.1002/ajmg.c.30085. Am J Med Genet C Semin Med Genet. 2006. PMID: 16602098 Review. No abstract available.
Cited by
-
Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation.Health Technol Assess. 2024 Jun;28(25):1-180. doi: 10.3310/PYTK6591. Health Technol Assess. 2024. PMID: 38938110 Free PMC article.
-
Psychosocial Impact of False-Positive Newborn Screening Results: A Scoping Review.Children (Basel). 2024 Apr 24;11(5):507. doi: 10.3390/children11050507. Children (Basel). 2024. PMID: 38790502 Free PMC article. Review.
-
Psychosocial Impact of a True-Positive, False-Positive, or Inconclusive Newborn Bloodspot Screening Result: A Questionnaire Study among Parents.Int J Neonatal Screen. 2024 Mar 5;10(1):18. doi: 10.3390/ijns10010018. Int J Neonatal Screen. 2024. PMID: 38535122 Free PMC article.
-
Psychosocial issues and coping strategies in families affected by long-chain fatty acid oxidation disorders.JIMD Rep. 2023 Dec 5;65(1):25-38. doi: 10.1002/jmd2.12402. eCollection 2024 Jan. JIMD Rep. 2023. PMID: 38186849 Free PMC article.
-
Parental Experiences with Newborn Screening and Gene Replacement Therapy for Spinal Muscular Atrophy.J Neuromuscul Dis. 2024;11(1):129-142. doi: 10.3233/JND-230082. J Neuromuscul Dis. 2024. PMID: 38160362 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
